</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
CB Partner Webinar 1 hour Vidium {{webinarsautomatedemailsregistrationconfirmation::client_only_logo}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_self_hosted}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_alt}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_width}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_custom_css}} {{webinarsautomatedemailsregistrationconfirmation::client_color}} {{webinarsautomatedemailsregistrationconfirmation::supported_by}} In this webinar, explore the clinical applications of cancer genomics in canine osteosarcoma. Dr. Esther Chon will provide an overview on osteosarcoma, how to incorporate genomics into daily clinical practice, and how genomic findings can expand treatment options for osteosarcoma management. Olaparib, the second drug in Vidum’s series of targeted therapies, will also be discussed. How to incorporate genomics into daily clinical practice The utility of genomic information in the management of canine osteosarcoma The canine-specific information for olaparib, the second drug in Vidum’s series of targeted therapies {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_4}} {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_5}} {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_6}}
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by Vidium. Thank you for registering for "#EVENTTITLE#."
In this webinar, explore the clinical applications of cancer genomics in canine osteosarcoma. Dr. Esther Chon will provide an overview on osteosarcoma, how to incorporate genomics into daily clinical practice, and how genomic findings can expand treatment options for osteosarcoma management. Olaparib, the second drug in Vidum’s series of targeted therapies, will also be discussed.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • How to incorporate genomics into daily clinical practice
  • The utility of genomic information in the management of canine osteosarcoma
  • The canine-specific information for olaparib, the second drug in Vidum’s series of targeted therapies
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  1 hour
Sponsored by Vidium
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The Vidium Team
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by Vidium. Thank you for registering for "#EVENTTITLE#."
In this webinar, explore the clinical applications of cancer genomics in canine osteosarcoma. Dr. Esther Chon will provide an overview on osteosarcoma, how to incorporate genomics into daily clinical practice, and how genomic findings can expand treatment options for osteosarcoma management. Olaparib, the second drug in Vidum’s series of targeted therapies, will also be discussed.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • How to incorporate genomics into daily clinical practice
  • The utility of genomic information in the management of canine osteosarcoma
  • The canine-specific information for olaparib, the second drug in Vidum’s series of targeted therapies
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  1 hour
Sponsored by Vidium
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The Vidium Team